Strategies for minimal residual disease detection: current perspectives
Giacomo Andreani, Daniela Cilloni Department of Clinical and Biological Sciences, University of Turin, Turin, Italy Abstract: Currently, the post-remission treatment in acute leukemia is based on the genetic profile of leukemic cells at diagnosis (ie, FLT3 ITD positivity) and on the level of measura...
Enregistré dans:
Auteurs principaux: | Andreani G, Cilloni D |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/be6c2eb12ce74ebb9ab03ad515312d13 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia
par: Hefazi M, et autres
Publié: (2018) -
Complications and management of coagulation disorders in leukemia patients
par: Lad DP, et autres
Publié: (2017) -
Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
par: Zhang CL, et autres
Publié: (2012) -
MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013) -
Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015)